CLEVELAND, Jan. 6, 2015 /PRNewswire/
-- DATATRAK International, Inc. (OTCQX: DTRK),
the leader in developing cloud-based, unified
eClinical® technologies and delivering related
services for the clinical trials industry, today announced that its
Chairman and CEO, Mr. Laurence P.
Birch, will present at the Noble Financial Capital Markets
11th Annual Investor Conference on January 19, 2015, at 9:30am EST.
"DATATRAK delivers differentiated benefits that
reduce the time and cost associated with clinical research with our
eClinical solutions and services," said Mr. Birch. "The latest
release to the DATATRAK ONE® Unified
Experience™ provides enterprise-wide functionality,
transforming the way sponsors and CROs access and analyze their
data. With instant access to cross-study data and custom
reporting tools to get the right information to the right person
faster, informed decisions can quickly be made. That leads to
better site compliance, better data, and ultimately a safer
trial. Clients and investors will quickly see the benefits of
the Unified Experience™."
The DATATRAK ONE® Unified Platform is the foundation of
DATATRAK efficiencies, providing a single data source
that powers all DATATRAK solutions, eliminating
data integration. We offer industry-leading system reliability
powered by the cloud, with an exceptional User Interface and a
greater overall value.
At the time of the presentation, a live audio and
high-definition video webcast of the DATATRAK
presentation will be available on the Noble Financial
website. Visit www.nobleresearch.com for more information on
the webcast.
Join DATATRAK Thought Leaders:
- Twitter
- LinkedIn
- SlideShare
- The DATATRAK Blog
Tweet: DATATRAK #UnifiedExperience time and cost savings to be
presented at the Noble Financial Capital Markets Conference
http://bit.ly/1xw0Aro
About
DATATRAK International,
Inc.
DATATRAK International is a worldwide technology
and services company delivering unified
eClinical® solutions and related services for the
clinical trials industry. DATATRAK built its
multi-component, comprehensive solution on a single, unified
platform and expanded this concept to include services delivery via
DATATRAK's Clinical and Consulting Services group.
The Company delivers a complete portfolio of software products
designed to accelerate the reporting of clinical research data from
sites to sponsors and ultimately regulatory authorities, faster and
more efficiently than loosely integrated technologies. The
DATATRAK ONE® software solution,
deployed worldwide through an ASP or Enterprise Transfer offering,
supports Preclinical and Phase I - Phase IV drug and device studies
in multiple languages throughout the world. DATATRAK
is located in Cleveland, Ohio;
Bryan, Texas; Cary (RTP),
North Carolina, Chicago, Illinois; and London, England. For more information,
visit http://www.datatrak.com.
Except for the historical information contained in this press
release, the statements made in this release are forward-looking
statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates
and current beliefs concerning the operations, future results and
prospects of the Company and are subject to uncertainties and
factors which are difficult to predict and, in many instances, are
beyond the control of the Company, and which could cause actual
results to differ materially from those contemplated in these
forward-looking statements. For a list of certain factors that may
cause actual results to differ materially from those contemplated
in these forward looking statements, please see the Company's
report filed with the OTCQX Market on November 13, 2014 announcing its results for the
third quarter 2014. The Company undertakes no obligation to update
publicly or revise any forward-looking statement whether as a
result of new information, future events or otherwise.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/datatrak-to-present-at-noble-financial-capital-markets-11th-annual-investor-conference-300016091.html
SOURCE DATATRAK International, Inc.